SCHEMBL19249094

SCHEMBL19249094

N=Cc1c(N)cc(C(F)(F)F)cc1NCc1cccc(C(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDO2 P48775 3/20 0.50
▸ APP P05067 2/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.44
▸ EGFR P00533 2/20 0.44
▸ RPS6KB1 P23443 5/20 0.43
▸ AURKA O14965 3/20 0.43
▸ AURKB Q96GD4 2/20 0.43
▸ KCNN3 Q9UGI6 1/20 0.43
▸ TAAR1 Q96RJ0 1/20 0.41
▸ FFAR1 O14842 1/20 0.41
▸ FFAR4 Q5NUL3 1/20 0.41
▸ IDO1 P14902 1/20 0.40
▸ HDAC3 O15379 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ MITF O75030 1/20 0.40
▸ PTPN5 P54829 1/20 0.40
▸ CHEK1 O14757 1/20 0.40
▸ DAPK3 O43293 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19249350 0.78 MRGPRX4 (0.36) TDO2RXFP1ROCK2ROCK1
SCHEMBL19249226 0.76 TDO2 (0.34) TDO2RXFP1EGFRROCK2ROCK1
SCHEMBL29721496 0.73 APP (0.48) TDO2APPRXFP1EGFRRPS6KB1
SCHEMBL20129864 0.73 APP (0.48) TDO2APPRXFP1EGFRRPS6KB1
SCHEMBL19249228 0.71 PTPN5 (0.42) IDO1PTPN5
SCHEMBL19249331 0.70 CYP1A2 (0.43) TDO2EGFRRPS6KB1AURKAAURKB
SCHEMBL18983680 0.70 ALDH1A1 (0.60) APPRXFP1PTPN5
SCHEMBL22084443 0.69 BACE1 (0.40) APPIDO1HDAC1HDAC6
SCHEMBL27816900 0.69 TSHR (0.56) TDO2APPRXFP1EGFRRPS6KB1
SCHEMBL5534504 0.69 RXFP1 (0.56) TDO2APPRXFP1EGFRRPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017133258-A1 1H-INDAZOLE DERIVATIVE AND USE THEREOF AS IDO INHIBITOR 西华大学 2017-08-10 — — WO disclosed
Send feedback